ArticleHepatology communications2026
Micronutrient deficiencies in ambulatory adults with cirrhosis.
Article in Hepatology communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundDespite the well-established relationship between micronutrient deficiencies and cirrhosis, little is known of micronutrient deficiencies among ambulatory patients with cirrhosis awaiting liver transplant (LT). We aimed to characterize micronutrient deficiencies among patients with cirrhosis awaiting LT and assess their association with frailty, a complication with high morbidity and mortality.
methodsAmbulatory adult patients with cirrhosis awaiting LT from June 2024 to March 2025 were tested for micronutrient deficiencies in clinical practice. Multivariable modeling was used to assess the association between frailty and micronutrient deficiencies.
resultsOf 275 patients, the median (IQR) age was 60 (51-66) years and 114 (42%) were women. Median MELD 3.0 (IQR) was 17 (12-22), and 64 (23%) were frail. Micronutrient deficiencies were common, especially of zinc, vitamin D/E/B12, and selenium. Compared to patients who were not frail, frail patients were more likely to have vitamin B12 deficiency (34% vs. 18%, p=0.01), vitamin E deficiency (36% vs. 20%, p=0.02), and selenium deficiency (28% vs. 13%, p=0.01). Patients with vitamin B12, vitamin E, or selenium deficiency had 2.56 (95% CI: 1.04-6.20), 2.55 (95% CI: 1.06-6.11), and 3.00 (95% CI: 1.15-7.68) increased odds of frailty on univariable analysis. When controlling for confounders, selenium deficiency alone remained independently associated with frailty (adjusted OR: 2.55, 95% CI: 1.18-5.54, p=0.02).
conclusionsDeficiencies of zinc, vitamin A/D/E/B12, and selenium are common in patients with cirrhosis awaiting LT and may represent a pragmatic panel of micronutrients to send in clinical practice. Selenium deficiency, in particular, was independently associated with frailty. Future studies should assess micronutrient repletion as a possible therapy in the multipronged approach to reversing frailty in patients with cirrhosis, as in the general population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.